Laboratory diagnostics for HIV infection

Annali dell'Istituto Superiore di Sanita

Volumn 46, Issue 1, 2010, Pages 24-33

  Buttò, Stefano ^a   Suligoi, Barbara ^a   Fanales Belasio, Emanuele ^a   Raimondo, Mariangela ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Biological assay; Diagnosis; HIV; Laboratory techniques and procedures

Indexed keywords

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; SERODIAGNOSIS;

AIDS SERODIAGNOSIS; HIV INFECTIONS; HUMANS;

EID: 77949868585     PISSN: 00212571     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0021-25712010000100004     Document Type: Article

References (66)

1. Fanales-Belasio E, Raimondo M, Suligoi B, Buttò S. HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanità 2010;46(1):5-14.
2. Weber B. Screening of HIV infection: role of molecular and immunological assays. Expert Rev Mol Diagn 2006;6:399-411.
3. Kahn JO, Walker B.D. Acute human immunodeficiency virus type1 infection. N Engl J Med 1998;339:33-39
4. Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT , Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch M.P. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003;17:1871-1879
5. Steckelberg JM, Cockerill FR 3rd. Serologic testing for human immunodeficiency virus antibodies. Mayo Clin Proc 1988;63:373-380
6. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch M.P. National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. N Engl J Med 2004;351:760-768
7. Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, Shaw GM, Busch M.P. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:305-310
8. Lange JM, Parry JV, de Wolf F, Mortimer PP, Goudsmit J. Diagnostic value of specific IgM antibodies in primary HIV infection. AIDS 1988;2:31-35
9. T omaras GD, Yates NL, Liu P, Qin L, Fouda GG, Chavez LL, Decamp AC , Parks RJ, Ashley VC, Lucas JT, Cohen M, Eron J, Hicks CB, Liao HX, Self SG, Landucci G, Forthal DN, Weinhold KJ, Keele BF, Hahn BH, Greenberg ML, Morris L, Karim SS, Blattner WA, Montefiori DC, Shaw GM, Perelson AS, Haynes BF. Initial B-Cell responses to transmitted human immunodeficiency virus type 1: virionbinding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J Virol 2008;82:12449-12463
10. Murphy J, Parry V. Assays for the detection of recent infections with human immunodeficiency virus type 1. eurosurveillance 2008;13:4-10.
11. Wilson KM, Johnson EI, Croom HA, Richards KM, Doughty L, Cunningham PH, Kemp BE, Branson BM, Dax EM. Incidence immunoassay for distinguishing recent from established HIV-1 infection in therapy-naive populations. AIDS 2004;18:2253-2259
12. Salahuddin SZ, Groopman JE, Markham PD, Sarngadharan MG, Redfield RR, McLane MF, Essex M, Sliski A, Gallo RC . HTLV-III in symptom-free seronegative persons. Lancet 1984;2:1418-1420
13. Gürtler L. Difficulties and strategies of HIV diagnosis. Lancet 1996;348:176-179
14. Berger A, Preiser W, Doerr HW. The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol 2001;20:23-30.
15. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global programme on AIDS. Recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1992;67:145-149
16. Joint United Nations Programme on HIV/AIDS (UNAIDS). Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997;72:81-88
17. Brust S, Duttmann H, Feldner J, Gürtler L, Thorstensson R, Simon F. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods 2000;90:153-165
18. A ndersson S, Asjö B, Jenum PA, Manner I, Njölstad G, Ragnhildstveit E, Skaug K, Söderquist B, von Sydow M. Relevance of a combined HIV antigen/antibody assay to detect early HIV infections in low prevalence population: case reports. Clin Lab 2004;50:409-413
19. Meier T, Knoll E, Henkes M, Enders G, Braun R. Evidence for a diagnostic window in fourth generation assays in HIV-1. J Clin Virol 2001;23:113-116
20. Cordes R, Ryan M. Pitfalls in HIV testing. Postgraduate Medicine 1995;98:177.
21. Weber B, Moshtaghi-Boronjeni M, Brunner M, Preiser W, Breiner M, Doerr HW. Evaluation of the reliability of six current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods 1995;55:97.
22. Mac Kenzie WR, Davis JP, Peterson DE, Hibbard AJ, Becker G, Zarvan BS. Multiple false-positive serologic tests for HIV, HTLV-1 and hepatitis C following influenza vaccination, 1991. JAMA 1992;268:1015-1017
23. Arnold NL, Slade BA, Jones MM, Popovsky MA. Donor follow up of influenza vaccine-related multiple viral enzyme immunoassay reactivity. Vox Sang 1994;67:191-194
24. C hallakere K, Rapaport M. False-positive human immunodeficiency virus type 1 ELISA results in low-risk subjects. West J Med 1993;159:214-215
25. Lee D, Eby W, Molinaro G. HIV false positivity after hepatitis B vaccination. Lancet 1992;339:1060.
26. Pearlman ES, Ballas SK. False-positive human immunodeficiency virus screening test related to rabies vaccination. Arch Pathol Lab Med 1994;118:805-806
27. Dock NL, Lamberson HV Jr, O'Brien TA , Tribe DE, Alexander SS, Poiesz BJ. Evaluation of atypical human immunodeficiency virus immunoblot reactivity in blood donors. Transfusion 1988;28:412-418
28. Jindal R, Solomon M, Burrows L. False positive tests for HIV in a woman with lupus and renal failure. N Engl J Med 1993;328:1281-1282
29. Ng V. Serological diagnosis with recombinant peptides/proteins. Clin Chem 1991;37:1667-1668
30. Biggar RJ, Gigase PL, Melbye M, Kestens L, Sarin PS, Bodner AJ, Demedts P, Stevens WJ, Paluku L, Delacollette C, Blattner WA. ELISA HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet 1985;2:520-523
31. Moore J, Cone E, Alexander S. HTLV-III (HIV) seropositivity in 1971-1972 parenteral drug abusers - a case of false-positives or evidence of viral exposure? N Engl J Med 1986;314:1387-1388
32. Blanton M, Balakrishnan K, Dumaswala U, Zelenski K, Greenwalt TJ. HLA antibodies in blood donors with reactive screening tests for antibody to the immunodeficiency virus. Transfusion 1987;27:118-119
33. Bylund D, Ziegner U, Hooper D. Review of testing for human immunodeficiency virus. Clin Lab Med 1992;12:305-333
34. Steckelberg JM, Cockerill F. Serologic testing for human immunodeficiency virus antibodies. Mayo Clin Proc 1988; 63:373-380
35. Profitt MR, Yen-Lieberman B. Laboratory diagnosis of human immunodeficiency virus infection. Inf Dis Clin North Am 1993;7:203-219
36. Schleupner CJ. Detection of HIV-1 infection. In: Mandell GI, Douglas RG, Bennett JE (Ed.). Principles and practice of infectious diseases, 3ed. New York: Churchill Livingstone; 1990. p. 1092.
37. Centers for Disease Control (CDC). Interpretive criteria used to report western blot results for HIV-1-antibody testing-United States. MMWR Morb Mortal Wkly Rep 1991;40:692-695
38. T ebourski F, Slim A, Elgaaied A. The significance of combining World Health Organization and Center for Disease Control criteria to resolve indeterminate human immunodeficiency virus type-1 Western blot results. Diagn Microbiol Infect Dis 2004;48:59-61.
39. O'Gorman MR, Weber D, Landis SE, Schoenbach VJ, Mittal M, Folds JD. Interpretive criteria of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infection. Arch Pathol Lab Med 1991;115:26-30.
40. T he Consortium for Retrovirus Serology Standardization. Serological diagnosis of human immunodeficiency virus infection by Western blot testing. JAMA 1988;260:674-679
41. Giles RE, Perry KR, Parry JV. Simple/rapid test devices for anti-HIV screening: do they come up to the mark? J Med Virol 1999;59:104-109
42. E kwueme DU, Pinkerton SD, Holtgrave DR, Branson BM. Cost comparison of three HIV counseling and testing technologies. Am J Prev Med 2003;25:112-121
43. Lillo F, Varnier OE, Mantia E, Terragna A, van der Groen G, Van Kerckhoven I, Mortimer PP, Parry JV, Bayliss G, Tamashiro H. Detection of HIV-1 antibodies in blood specimens spotted on filter-paper. Bull World Health Organ 1992;70:323-326
44. Kagulire SC, Stamper PD, Opendi P, Nakavuma JL, Mills LA, Makumbi F, Gray RH, Serwadda D, Reynolds SJ. Performance of two commercial immunochromatographic assays for rapid detection of antibodies specific to human immunodeficiency virus types 1 and 2 in serum and urine samples in a rural community-based research setting (Rakai, Uganda). Clin Vaccine Immunol 2007;14:738-740
45. T amashiro H, Constantine NT. Serological diagnosis of HIV infection using oral fluid samples. Bull World Health Organ 1994;72:135-143
46. C laassen M, van Zyl GU, Korsman SN, Smit L, Cotton MF, Preiser W. Pitfalls with rapid HIV antibody testing in HIVinfected children in the Western Cape, South Africa. J Clin Virol 2006;37:68-71.
47. Black V, von Mollendorf CE, Moyes JA, Scott LE, Puren A, Stevens WS. Poor sensitivity of field rapid HIV testing: implications for mother-to-child transmission programme. BJOG 2009;116:1805-1808
48. Stekler JD, Swenson PD, Coombs RW, Dragavon J, Thomas KK, Brennan CA, Devare SG, Wood RW, Golden MR. HIV testing in a high-incidence population: is antibody testing alone good enough? Clin Infect Dis 2009;49:444-453
49. Gray RH, Makumbi F, Serwadda D, Lutalo T, Nalugoda F, Opendi P, Kigozi G, Reynolds SJ, Sewankambo NK, Wawer MJ. Limitations of rapid HIV-1 tests during screening for trials in Uganda: diagnostic test accuracy study. BMJ 2007;335:188.
50. A nzala O, Sanders EJ, Kamali A, Katende M, Mutua GN, Ruzagira E, Stevens G, Simek M, Price M. Sensitivity and specificity of HIV rapid tests used for research and voluntary counselling and testing. East Afr Med J 2008;85:500-504
51. World Health Organization. Rapid HIV tests: guidelines for use in HIV testing and counselling services in resource-constrained settings. Geneva: WHO; 2004. Available from: www.emro.who.int/aiecf/web28.pdf .
52. Berger A, Preiser W. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 2002;9:713-721
53. Drosten C, Panning M, Drexler JF, Hänsel F, Pedroso C, Yeats J, de Souza Luna LK, Samuel M, Liedigk B, Lippert U, Stürmer M, Doerr HW, Brites C, Preiser W. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin Chem 2006;52:1258-1266
54. Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W. Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group. HIV-1 viral load assays for resource-limited settings. PLoS Med 2006;3:e417.
55. Pillonel J, Laperche S, Etablissement Francais du Sang. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT ). Euro Surveillance 2005;10:5-8. Surveillance Report, available from: www.eurosurveillance.org/ ViewArticle.aspx?ArticleId=519.
56. Laperche S, Morel P, Deschaseaux M, Bouchardeau F, Alimardani G, Guillaume N, Rouger P, Lefrère JJ. HIV antibody screening remains indispensable for ensuring viral safety of blood components despite NAT implementation. Transfusion 2003;43:1428-1432
57. C unningham CK, Charbonneau TT, Song K, Patterson D, Sullivan T, Cummins T, Poiesz B. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J 1999;18:30-35.
58. Pane F, Buttò S, Gobbo ML, Franco M, Butteroni C, Pastore L, Maiorano G, Foggia M, Tullio Cataldo P, Guarino A, Tamburrini E, Solinas S, Piazza M, Vecchio G, Verani P, Salvatore F. Direct detection of proviral gag segment of HIV in peripheral blood lymphocytes by a colorimetric PCR assay as a clinical laboratory tool applied to different at risk populations. J Clin Microbiol 1995;33:641-647
59. Janssen RS, Satten GA, Stramer SL, Rawal BD, O'Brien TR, Weiblen BJ, Hecht FM, Jack N, Cleghorn FR, Kahn JO, Chesney MA, Busch M.P. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8. Published erratum appears in JAMA 1999;281:1893.
60. Machado DM, Delwart EL, Diaz RS, de Oliveira CF, Alves K, Rawal BD, Sullivan M, Gwinn M, Clark KA, Busch M.P. Use of the sensitive/less-sensitive (detuned) EIA strategy for targeting genetic analysis of HIV-1 to recently infected blood donors. AIDS 2002;16:113-119
61. Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003;33:625-634
62. Parekh B, Kennedy MS, Dobbs T. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retrov 2002;18:295-307.
63. Suligoi B, Raimondo M, Fanales-Belasio E, Buttò S. The epidemic of HIV infection and AIDS, promotion of testing, and innovative strategies. Ann Ist Super Sanità 2010;46(1):15-23.
64. Suligoi B, Galli C, Massi M, Di Sora F, Sciandra M, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 2002;40:4015-4020
65. Suligoi B. Massi M, Galli C, Sciandra M, Di Sora F, Pezzotti P, Recchia O, Montella F, Sinicco A, Rezza G. Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr 2003;32:424-428
66. Suligoi B, Buttò S, Galli C, Bernasconi D, Salata RA, Tavoschi L, Chiappi M, Mugyenyi P, Pimpinelli F, Kityo C, Regine V, Rezza G. Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity. J Clin Virol 2008;41:288-292